Department of Medicine, R.U. in Molecular Medicine and Biotechnology, University Campus Bio-Medico of Rome, 00128 Rome, Italy.
Clinical Trial Center, Biostatistics and Bioinformatics Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Int J Mol Sci. 2021 Nov 8;22(21):12071. doi: 10.3390/ijms222112071.
Chemoresistance is a hallmark of malignant pleural mesothelioma (MPM) management and the expression of ALDH1A3 is responsible for the survival and activity of MPM chemoresistant cell subpopulations (ALDH cells). We enriched mesothelioma ALDH cells to near homogeneity by FACS sorting and an Aldefluor assay and performed unbiased Affymetrix gene expression profiling. Viability and ELISA assays were used to rule out significant apoptosis in the sorted cell subpopulations and to assess target engagement by butein. Statistical analysis of the results, pathway enrichment and promoter enrichment were employed for the generation of the data. Q-RTPCR was used to validate a subset of the identified, modulated mRNAs In this work, we started from the observation that the mRNA levels of the ALDH1A3 isoform could prognostically stratify MPM patients. Thus, we purified MPM ALDH cells from NCI-H2595 cells and interrogated their gene expression (GES) profile. We analyzed the GES of the purified cells at both a steady state and upon treatment with butein (a multifunctional tetrahydroxy-chalcone), which abates the ALDH cell number, thereby exerting chemo-sensitizing effects in vitro and in vivo. We identified 924 genes modulated in a statistically significant manner as a function of ALDH status and of the response to the inhibitor. Pathway and promoter enrichment identified the molecular determinant of high ALDH status and how butein treatment altered the molecular portrait of those chemoresistant cell subpopulations. Further, we unraveled an eighteen-gene signature with high prognostic significance for MPM patients, and showed that most of the identified prognostic contributors escaped the analysis of unfractionated samples. This work proves that digging into the unexplored field of intra-tumor heterogeneity (ITH) by working at the cell subpopulation level may provide findings of prognostic relevance, in addition to mechanistic insights into tumor resistance to therapy.
化学耐药性是恶性胸膜间皮瘤(MPM)管理的标志,ALDH1A3 的表达负责 MPM 化学耐药细胞亚群(ALDH 细胞)的存活和活性。我们通过 FACS 分选和 Aldefluor 测定法对间皮瘤 ALDH 细胞进行了近乎同质的富集,并进行了无偏倚的 Affymetrix 基因表达谱分析。活力和 ELISA 测定用于排除分选细胞亚群中明显的细胞凋亡,并评估丁布对目标的结合。对结果进行了统计分析、通路富集和启动子富集,以生成数据。使用 Q-RTPCR 验证了鉴定的、调节的 mRNA 的子集。在这项工作中,我们从观察到 ALDH1A3 同工型的 mRNA 水平可以对 MPM 患者进行预后分层开始。因此,我们从 NCI-H2595 细胞中纯化了 MPM ALDH 细胞,并检测了它们的基因表达(GES)谱。我们分析了纯化细胞在稳态和丁布(多功能四羟基查尔酮)处理下的 GES,丁布可以减少 ALDH 细胞数量,从而在体外和体内发挥化疗增敏作用。我们确定了 924 个基因,这些基因的表达在统计学上与 ALDH 状态和对抑制剂的反应有关。通路和启动子富集确定了高 ALDH 状态的分子决定因素,以及丁布处理如何改变这些化学耐药细胞亚群的分子特征。此外,我们揭示了一个具有高预后意义的十八基因标志物,表明大多数鉴定出的预后贡献者逃避了未分馏样本的分析。这项工作证明,通过在细胞亚群水平上挖掘肿瘤内异质性(ITH)的未知领域,除了为肿瘤对治疗的耐药机制提供见解外,还可能提供具有预后相关性的发现。